This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Celex Oncology Innovations Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Leif Helth Jensen - Innovator in Oncology
Introduction
Leif Helth Jensen is an inventor based in Vitznau, Switzerland. He is associated with Celex Oncology Innovations Ltd., where he contributes to advancements in cancer treatment. Although he currently holds no granted patents, his work is focused on innovative solutions in the field of oncology.
Latest Patent Applications
Leif's latest patent applications include:
1. **Composition for Enhancing Urolithin Production in a Human Subject** - This invention relates to a composition comprising a preparation of ellagitannins and/or ellagic acid and one or more human milk oligosaccharides (HMOs). The method aims to increase the production of urolithin A and/or other urolithins in the gut by administering the composition to a human subject.
2. **Treatment of Cancer and Inhibition of Metastasis** - This application discloses compounds and methods for reducing or preventing metastatic behavior in VGSC expressing cancer. The focus is on reducing the persistent part of the voltage-gated sodium channel current without eliminating the transient part.
Conclusion
Leif Helth Jensen is making significant strides in the field of oncology through his innovative patent applications. His work aims to enhance cancer treatment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile